|
Le, M; Okuyama, T; Cai, S R et al. (1997) Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy. Blood 89:1254-9
|
|
Okuyama, T; Huber, R M; Bowling, W et al. (1996) Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Hum Gene Ther 7:637-45
|
|
Pearline, R V; Lin, Y Z; Shen, K J et al. (1996) Alterations in enzymatic functions in hepatocytes and hepatocellular carcinomas from Ras-transduced livers resemble the effects of insulin. Hepatology 24:838-48
|
|
Lin, Y Z; Brunt, E M; Bowling, W et al. (1995) Ras-transduced diethylnitrosamine-treated hepatocytes develop into cancers of mixed phenotype in vivo. Cancer Res 55:5242-50
|
|
Kennedy, S; Rettinger, S; Flye, M W et al. (1995) Experiments in transgenic mice show that hepatocytes are the source for postnatal liver growth and do not stream. Hepatology 22:160-8
|
|
Hafenrichter, D G; Ponder, K P; Rettinger, S D et al. (1994) Optimization of liver-directed retroviral gene delivery. Transplant Proc 26:3379-80
|
|
Rettinger, S D; Kennedy, S C; Wu, X et al. (1994) Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci U S A 91:1460-4
|
|
Hafenrichter, D G; Wu, X; Rettinger, S D et al. (1994) Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood 84:3394-404
|
